Portal de investigación
Longterm Efficacy and Safety of Monotherapy versus Combination Therapy in Systemic Sclerosis-associated Pulmonary Arterial Hypertension: A Retrospective RESCLE Registry Study.
Fecha de publicación:
Fecha Ahead of Print:
Autores de IIS La Fe
-
Manuel Francisco Rubio Vallejo
Autor
-
Carles Tolosa Villela
Autor
-
Eric Freire Alvarez
Autor
Participantes ajenos a IIS La Fe
- Pestaña-Fernández M
- Guillén-Del-Castillo A
- Vargas-Hitos JA
- Rodríguez-Carballeira M
- Marín-Ballvé A
- Espinosa G
- Colunga-Argüelles D
- Ortego-Centeno N
- Trapiella-Martínez L
- Carbonell-Muñoz C
- Pla-Salas X
- Perales-Fraile I
- Corbella X
- Fonollosa-Pla V
- Simeón-Aznar CP
- RESCLE investigators, Autoimmune Diseases Study Group (GEAS)
Grupos
-
Investigacion clínica en enfermedades crónicas e Infección por el VIH
Investigador establecido
Marta Montero Alonso
Abstract
Monotherapy is an option as first-line therapy for pulmonary arterial hypertension (PAH). However, combination therapy is a beneficial alternative. Our objective was to evaluate the efficacy of monotherapy versus combination therapy in patients with systemic sclerosis (SSc)-associated PAH.
Datos de la publicación
- ISSN/ISSNe:
- 0315-162X, 1499-2752
- Tipo:
- Article
- Páginas:
- 89-98
- PubMed:
- 30770503
- Factor de Impacto:
- 1,577 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
JOURNAL OF RHEUMATOLOGY J RHEUMATOL PUBL CO
Citas Recibidas en Web of Science: 10
Documentos
- No hay documentos
Filiaciones
- Pestaña-Fernández M:
- From the Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de Llobregat, BarcelonaDepartment of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí, Sabadell, BarcelonaUnit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron, BarcelonaUnit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo, Vigo, PontevedraDepartment of Internal Medicine, Hospital Universitario Virgen de las Nieves, GranadaDepartment of Internal Medicine, Hospital Universitario y Politécnico La Fe, ValenciaDepartment of Internal Medicine, Hospital Universitario Mútua Terrassa, Terrassa, BarcelonaUnit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa, ZaragozaDepartment of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic, BarcelonaDepartment of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, AsturiasUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada, GranadaUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes, Gijón, AsturiasDepartment of Internal Medicine, Complejo Asistencial Universitario de Salamanca, SalamancaUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic, Vic, BarcelonaDepartment of Internal Medicine, Hospital Universitario Rey Juan Carlos, Móstoles, MadridFaculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain. This project was possible thanks to an unrestricted educational scholarship granted by Laboratorios Actelion. M. Pestaña-Fernández, MD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de LlobregatM. Rubio-Rivas, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de LlobregatA. Guillén-Del-Castillo, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron
- Rubio-Rivas M:
- From the Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de Llobregat, BarcelonaDepartment of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí, Sabadell, BarcelonaUnit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron, BarcelonaUnit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo, Vigo, PontevedraDepartment of Internal Medicine, Hospital Universitario Virgen de las Nieves, GranadaDepartment of Internal Medicine, Hospital Universitario y Politécnico La Fe, ValenciaDepartment of Internal Medicine, Hospital Universitario Mútua Terrassa, Terrassa, BarcelonaUnit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa, ZaragozaDepartment of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic, BarcelonaDepartment of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, AsturiasUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada, GranadaUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes, Gijón, AsturiasDepartment of Internal Medicine, Complejo Asistencial Universitario de Salamanca, SalamancaUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic, Vic, BarcelonaDepartment of Internal Medicine, Hospital Universitario Rey Juan Carlos, Móstoles, MadridFaculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain. This project was possible thanks to an unrestricted educational scholarship granted by Laboratorios Actelion. M. Pestaña-Fernández, MD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de LlobregatM. Rubio-Rivas, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de LlobregatA. Guillén-Del-Castillo, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron
- Tolosa-Vilella C:
- From the Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de Llobregat, BarcelonaDepartment of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí, Sabadell, BarcelonaUnit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron, BarcelonaUnit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo, Vigo, PontevedraDepartment of Internal Medicine, Hospital Universitario Virgen de las Nieves, GranadaDepartment of Internal Medicine, Hospital Universitario y Politécnico La Fe, ValenciaDepartment of Internal Medicine, Hospital Universitario Mútua Terrassa, Terrassa, BarcelonaUnit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa, ZaragozaDepartment of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic, BarcelonaDepartment of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, AsturiasUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada, GranadaUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes, Gijón, AsturiasDepartment of Internal Medicine, Complejo Asistencial Universitario de Salamanca, SalamancaUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic, Vic, BarcelonaDepartment of Internal Medicine, Hospital Universitario Rey Juan Carlos, Móstoles, MadridFaculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain. This project was possible thanks to an unrestricted educational scholarship granted by Laboratorios Actelion. M. Pestaña-Fernández, MD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de LlobregatM. Rubio-Rivas, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de LlobregatA. Guillén-Del-Castillo, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron
- Guillén-Del-Castillo A:
- From the Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de Llobregat, BarcelonaDepartment of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí, Sabadell, BarcelonaUnit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron, BarcelonaUnit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo, Vigo, PontevedraDepartment of Internal Medicine, Hospital Universitario Virgen de las Nieves, GranadaDepartment of Internal Medicine, Hospital Universitario y Politécnico La Fe, ValenciaDepartment of Internal Medicine, Hospital Universitario Mútua Terrassa, Terrassa, BarcelonaUnit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa, ZaragozaDepartment of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic, BarcelonaDepartment of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, AsturiasUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada, GranadaUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes, Gijón, AsturiasDepartment of Internal Medicine, Complejo Asistencial Universitario de Salamanca, SalamancaUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic, Vic, BarcelonaDepartment of Internal Medicine, Hospital Universitario Rey Juan Carlos, Móstoles, MadridFaculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain. This project was possible thanks to an unrestricted educational scholarship granted by Laboratorios Actelion. M. Pestaña-Fernández, MD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de LlobregatM. Rubio-Rivas, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de LlobregatA. Guillén-Del-Castillo, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron
- Freire M:
- From the Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de Llobregat, BarcelonaDepartment of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí, Sabadell, BarcelonaUnit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron, BarcelonaUnit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo, Vigo, PontevedraDepartment of Internal Medicine, Hospital Universitario Virgen de las Nieves, GranadaDepartment of Internal Medicine, Hospital Universitario y Politécnico La Fe, ValenciaDepartment of Internal Medicine, Hospital Universitario Mútua Terrassa, Terrassa, BarcelonaUnit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa, ZaragozaDepartment of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic, BarcelonaDepartment of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, AsturiasUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada, GranadaUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes, Gijón, AsturiasDepartment of Internal Medicine, Complejo Asistencial Universitario de Salamanca, SalamancaUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic, Vic, BarcelonaDepartment of Internal Medicine, Hospital Universitario Rey Juan Carlos, Móstoles, MadridFaculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain. This project was possible thanks to an unrestricted educational scholarship granted by Laboratorios Actelion. M. Pestaña-Fernández, MD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de LlobregatM. Rubio-Rivas, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de LlobregatA. Guillén-Del-Castillo, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron
- Vargas-Hitos JA:
- From the Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de Llobregat, BarcelonaDepartment of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí, Sabadell, BarcelonaUnit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron, BarcelonaUnit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo, Vigo, PontevedraDepartment of Internal Medicine, Hospital Universitario Virgen de las Nieves, GranadaDepartment of Internal Medicine, Hospital Universitario y Politécnico La Fe, ValenciaDepartment of Internal Medicine, Hospital Universitario Mútua Terrassa, Terrassa, BarcelonaUnit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa, ZaragozaDepartment of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic, BarcelonaDepartment of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, AsturiasUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada, GranadaUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes, Gijón, AsturiasDepartment of Internal Medicine, Complejo Asistencial Universitario de Salamanca, SalamancaUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic, Vic, BarcelonaDepartment of Internal Medicine, Hospital Universitario Rey Juan Carlos, Móstoles, MadridFaculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain. This project was possible thanks to an unrestricted educational scholarship granted by Laboratorios Actelion. M. Pestaña-Fernández, MD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de LlobregatM. Rubio-Rivas, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de LlobregatA. Guillén-Del-Castillo, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron
- Todolí-Parra JA:
- From the Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de Llobregat, BarcelonaDepartment of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí, Sabadell, BarcelonaUnit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron, BarcelonaUnit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo, Vigo, PontevedraDepartment of Internal Medicine, Hospital Universitario Virgen de las Nieves, GranadaDepartment of Internal Medicine, Hospital Universitario y Politécnico La Fe, ValenciaDepartment of Internal Medicine, Hospital Universitario Mútua Terrassa, Terrassa, BarcelonaUnit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa, ZaragozaDepartment of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic, BarcelonaDepartment of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, AsturiasUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada, GranadaUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes, Gijón, AsturiasDepartment of Internal Medicine, Complejo Asistencial Universitario de Salamanca, SalamancaUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic, Vic, BarcelonaDepartment of Internal Medicine, Hospital Universitario Rey Juan Carlos, Móstoles, MadridFaculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain. This project was possible thanks to an unrestricted educational scholarship granted by Laboratorios Actelion. M. Pestaña-Fernández, MD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de LlobregatM. Rubio-Rivas, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de LlobregatA. Guillén-Del-Castillo, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron
- Rodríguez-Carballeira M:
- From the Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de Llobregat, BarcelonaDepartment of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí, Sabadell, BarcelonaUnit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron, BarcelonaUnit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo, Vigo, PontevedraDepartment of Internal Medicine, Hospital Universitario Virgen de las Nieves, GranadaDepartment of Internal Medicine, Hospital Universitario y Politécnico La Fe, ValenciaDepartment of Internal Medicine, Hospital Universitario Mútua Terrassa, Terrassa, BarcelonaUnit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa, ZaragozaDepartment of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic, BarcelonaDepartment of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, AsturiasUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada, GranadaUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes, Gijón, AsturiasDepartment of Internal Medicine, Complejo Asistencial Universitario de Salamanca, SalamancaUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic, Vic, BarcelonaDepartment of Internal Medicine, Hospital Universitario Rey Juan Carlos, Móstoles, MadridFaculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain. This project was possible thanks to an unrestricted educational scholarship granted by Laboratorios Actelion. M. Pestaña-Fernández, MD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de LlobregatM. Rubio-Rivas, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de LlobregatA. Guillén-Del-Castillo, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron
- Marín-Ballvé A:
- From the Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de Llobregat, BarcelonaDepartment of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí, Sabadell, BarcelonaUnit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron, BarcelonaUnit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo, Vigo, PontevedraDepartment of Internal Medicine, Hospital Universitario Virgen de las Nieves, GranadaDepartment of Internal Medicine, Hospital Universitario y Politécnico La Fe, ValenciaDepartment of Internal Medicine, Hospital Universitario Mútua Terrassa, Terrassa, BarcelonaUnit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa, ZaragozaDepartment of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic, BarcelonaDepartment of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, AsturiasUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada, GranadaUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes, Gijón, AsturiasDepartment of Internal Medicine, Complejo Asistencial Universitario de Salamanca, SalamancaUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic, Vic, BarcelonaDepartment of Internal Medicine, Hospital Universitario Rey Juan Carlos, Móstoles, MadridFaculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain. This project was possible thanks to an unrestricted educational scholarship granted by Laboratorios Actelion. M. Pestaña-Fernández, MD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de LlobregatM. Rubio-Rivas, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de LlobregatA. Guillén-Del-Castillo, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron
- Espinosa G:
- From the Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de Llobregat, BarcelonaDepartment of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí, Sabadell, BarcelonaUnit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron, BarcelonaUnit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo, Vigo, PontevedraDepartment of Internal Medicine, Hospital Universitario Virgen de las Nieves, GranadaDepartment of Internal Medicine, Hospital Universitario y Politécnico La Fe, ValenciaDepartment of Internal Medicine, Hospital Universitario Mútua Terrassa, Terrassa, BarcelonaUnit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa, ZaragozaDepartment of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic, BarcelonaDepartment of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, AsturiasUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada, GranadaUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes, Gijón, AsturiasDepartment of Internal Medicine, Complejo Asistencial Universitario de Salamanca, SalamancaUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic, Vic, BarcelonaDepartment of Internal Medicine, Hospital Universitario Rey Juan Carlos, Móstoles, MadridFaculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain. This project was possible thanks to an unrestricted educational scholarship granted by Laboratorios Actelion. M. Pestaña-Fernández, MD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de LlobregatM. Rubio-Rivas, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de LlobregatA. Guillén-Del-Castillo, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron
- Colunga-Argüelles D:
- From the Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de Llobregat, BarcelonaDepartment of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí, Sabadell, BarcelonaUnit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron, BarcelonaUnit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo, Vigo, PontevedraDepartment of Internal Medicine, Hospital Universitario Virgen de las Nieves, GranadaDepartment of Internal Medicine, Hospital Universitario y Politécnico La Fe, ValenciaDepartment of Internal Medicine, Hospital Universitario Mútua Terrassa, Terrassa, BarcelonaUnit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa, ZaragozaDepartment of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic, BarcelonaDepartment of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, AsturiasUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada, GranadaUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes, Gijón, AsturiasDepartment of Internal Medicine, Complejo Asistencial Universitario de Salamanca, SalamancaUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic, Vic, BarcelonaDepartment of Internal Medicine, Hospital Universitario Rey Juan Carlos, Móstoles, MadridFaculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain. This project was possible thanks to an unrestricted educational scholarship granted by Laboratorios Actelion. M. Pestaña-Fernández, MD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de LlobregatM. Rubio-Rivas, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de LlobregatA. Guillén-Del-Castillo, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron
- Ortego-Centeno N:
- From the Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de Llobregat, BarcelonaDepartment of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí, Sabadell, BarcelonaUnit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron, BarcelonaUnit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo, Vigo, PontevedraDepartment of Internal Medicine, Hospital Universitario Virgen de las Nieves, GranadaDepartment of Internal Medicine, Hospital Universitario y Politécnico La Fe, ValenciaDepartment of Internal Medicine, Hospital Universitario Mútua Terrassa, Terrassa, BarcelonaUnit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa, ZaragozaDepartment of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic, BarcelonaDepartment of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, AsturiasUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada, GranadaUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes, Gijón, AsturiasDepartment of Internal Medicine, Complejo Asistencial Universitario de Salamanca, SalamancaUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic, Vic, BarcelonaDepartment of Internal Medicine, Hospital Universitario Rey Juan Carlos, Móstoles, MadridFaculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain. This project was possible thanks to an unrestricted educational scholarship granted by Laboratorios Actelion. M. Pestaña-Fernández, MD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de LlobregatM. Rubio-Rivas, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de LlobregatA. Guillén-Del-Castillo, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron
- Trapiella-Martínez L:
- From the Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de Llobregat, BarcelonaDepartment of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí, Sabadell, BarcelonaUnit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron, BarcelonaUnit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo, Vigo, PontevedraDepartment of Internal Medicine, Hospital Universitario Virgen de las Nieves, GranadaDepartment of Internal Medicine, Hospital Universitario y Politécnico La Fe, ValenciaDepartment of Internal Medicine, Hospital Universitario Mútua Terrassa, Terrassa, BarcelonaUnit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa, ZaragozaDepartment of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic, BarcelonaDepartment of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, AsturiasUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada, GranadaUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes, Gijón, AsturiasDepartment of Internal Medicine, Complejo Asistencial Universitario de Salamanca, SalamancaUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic, Vic, BarcelonaDepartment of Internal Medicine, Hospital Universitario Rey Juan Carlos, Móstoles, MadridFaculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain. This project was possible thanks to an unrestricted educational scholarship granted by Laboratorios Actelion. M. Pestaña-Fernández, MD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de LlobregatM. Rubio-Rivas, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de LlobregatA. Guillén-Del-Castillo, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron
- Carbonell-Muñoz C:
- From the Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de Llobregat, BarcelonaDepartment of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí, Sabadell, BarcelonaUnit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron, BarcelonaUnit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo, Vigo, PontevedraDepartment of Internal Medicine, Hospital Universitario Virgen de las Nieves, GranadaDepartment of Internal Medicine, Hospital Universitario y Politécnico La Fe, ValenciaDepartment of Internal Medicine, Hospital Universitario Mútua Terrassa, Terrassa, BarcelonaUnit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa, ZaragozaDepartment of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic, BarcelonaDepartment of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, AsturiasUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada, GranadaUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes, Gijón, AsturiasDepartment of Internal Medicine, Complejo Asistencial Universitario de Salamanca, SalamancaUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic, Vic, BarcelonaDepartment of Internal Medicine, Hospital Universitario Rey Juan Carlos, Móstoles, MadridFaculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain. This project was possible thanks to an unrestricted educational scholarship granted by Laboratorios Actelion. M. Pestaña-Fernández, MD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de LlobregatM. Rubio-Rivas, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de LlobregatA. Guillén-Del-Castillo, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron
- Pla-Salas X:
- From the Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de Llobregat, BarcelonaDepartment of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí, Sabadell, BarcelonaUnit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron, BarcelonaUnit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo, Vigo, PontevedraDepartment of Internal Medicine, Hospital Universitario Virgen de las Nieves, GranadaDepartment of Internal Medicine, Hospital Universitario y Politécnico La Fe, ValenciaDepartment of Internal Medicine, Hospital Universitario Mútua Terrassa, Terrassa, BarcelonaUnit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa, ZaragozaDepartment of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic, BarcelonaDepartment of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, AsturiasUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada, GranadaUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes, Gijón, AsturiasDepartment of Internal Medicine, Complejo Asistencial Universitario de Salamanca, SalamancaUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic, Vic, BarcelonaDepartment of Internal Medicine, Hospital Universitario Rey Juan Carlos, Móstoles, MadridFaculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain. This project was possible thanks to an unrestricted educational scholarship granted by Laboratorios Actelion. M. Pestaña-Fernández, MD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de LlobregatM. Rubio-Rivas, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de LlobregatA. Guillén-Del-Castillo, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron
- Perales-Fraile I:
- From the Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de Llobregat, BarcelonaDepartment of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí, Sabadell, BarcelonaUnit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron, BarcelonaUnit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo, Vigo, PontevedraDepartment of Internal Medicine, Hospital Universitario Virgen de las Nieves, GranadaDepartment of Internal Medicine, Hospital Universitario y Politécnico La Fe, ValenciaDepartment of Internal Medicine, Hospital Universitario Mútua Terrassa, Terrassa, BarcelonaUnit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa, ZaragozaDepartment of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic, BarcelonaDepartment of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, AsturiasUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada, GranadaUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes, Gijón, AsturiasDepartment of Internal Medicine, Complejo Asistencial Universitario de Salamanca, SalamancaUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic, Vic, BarcelonaDepartment of Internal Medicine, Hospital Universitario Rey Juan Carlos, Móstoles, MadridFaculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain. This project was possible thanks to an unrestricted educational scholarship granted by Laboratorios Actelion. M. Pestaña-Fernández, MD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de LlobregatM. Rubio-Rivas, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de LlobregatA. Guillén-Del-Castillo, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron
- Corbella X:
- From the Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de Llobregat, BarcelonaDepartment of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí, Sabadell, BarcelonaUnit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron, BarcelonaUnit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo, Vigo, PontevedraDepartment of Internal Medicine, Hospital Universitario Virgen de las Nieves, GranadaDepartment of Internal Medicine, Hospital Universitario y Politécnico La Fe, ValenciaDepartment of Internal Medicine, Hospital Universitario Mútua Terrassa, Terrassa, BarcelonaUnit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa, ZaragozaDepartment of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic, BarcelonaDepartment of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, AsturiasUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada, GranadaUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes, Gijón, AsturiasDepartment of Internal Medicine, Complejo Asistencial Universitario de Salamanca, SalamancaUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic, Vic, BarcelonaDepartment of Internal Medicine, Hospital Universitario Rey Juan Carlos, Móstoles, MadridFaculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain. This project was possible thanks to an unrestricted educational scholarship granted by Laboratorios Actelion. M. Pestaña-Fernández, MD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de LlobregatM. Rubio-Rivas, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de LlobregatA. Guillén-Del-Castillo, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron
- Fonollosa-Pla V:
- From the Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de Llobregat, BarcelonaDepartment of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí, Sabadell, BarcelonaUnit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron, BarcelonaUnit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo, Vigo, PontevedraDepartment of Internal Medicine, Hospital Universitario Virgen de las Nieves, GranadaDepartment of Internal Medicine, Hospital Universitario y Politécnico La Fe, ValenciaDepartment of Internal Medicine, Hospital Universitario Mútua Terrassa, Terrassa, BarcelonaUnit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa, ZaragozaDepartment of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic, BarcelonaDepartment of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, AsturiasUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada, GranadaUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes, Gijón, AsturiasDepartment of Internal Medicine, Complejo Asistencial Universitario de Salamanca, SalamancaUnit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic, Vic, BarcelonaDepartment of Internal Medicine, Hospital Universitario Rey Juan Carlos, Móstoles, MadridFaculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain. This project was possible thanks to an unrestricted educational scholarship granted by Laboratorios Actelion. M. Pestaña-Fernández, MD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de LlobregatM. Rubio-Rivas, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L'Hospitalet de LlobregatA. Guillén-Del-Castillo, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron
Keywords
- SYSTEMIC SCLEROSIS; PULMONARY ARTERIAL HYPERTENSION; SURVIVAL ANALYSIS
Proyectos y Estudios Clínicos
NUEVAS ESTRATEGIAS PARA EL TRATAMIENTO DE LAS INFECCIONES ASOCIADAS A BIOCAPAS FUNGICAS.
Investigador Principal: EMILIA CANTON LACASA
PI12/02786 . INSTITUTO DE SALUD CARLOS III . 2013
REGISTRO ESPAÑOL DE PACIENTES CON ESCLERODERMIA.
Investigador Principal: JOSÉ ANTONIO TODOLÍ PARRA
RESCLE . 2019
PREVENCIÓN DE EPISODIOS DE TROMBOEMBOLIA - REGISTRO EUROPEO SOBRE TROMBOEMBOLIA VENOSA.
Investigador Principal: JOSÉ ANTONIO TODOLÍ PARRA
DAI-VTE-2013-02 . 2014
ENSAYO CLINICO FASE III, DE GRUPOS PARALELOS, RANDOMIZADO, CONTROLADO CON PLACEBO, DOBLE CIEGO Y MULTICENTRICO, PARA EVALUAR LA EFICACIA Y SEGURIDAD DE LA ADMINISTRACION DE TOCILIZUMAB EN PACIENTES DIAGNOSTICADOS DE ORBITOPATÍA TIROIDEA (OT) MODERADA A SE VERA O QUE AMENAZA LA VISTA, QUE NO HAN RESPONDIDO ADECUADAMENTE AL TRATAMIENTO CON PULSOS DE CORTICOIDES.
Investigador Principal: ENRIQUE ESPAÑA GREGORI
GRC-TCL-2010-01 . 2013
Cita
Pestaña M,RUBIO M,TOLOSA C,Guillén A,FREIRE M,Vargas JA,TODOLÍ JA,Rodríguez M,Marín A,Espinosa G,Colunga D,Ortego N,Trapiella L,Carbonell C,Pla X,Perales I,Corbella X,Fonollosa V,Simeón CP,RESCLE ADSG(. Longterm Efficacy and Safety of Monotherapy versus Combination Therapy in Systemic Sclerosis-associated Pulmonary Arterial Hypertension: A Retrospective RESCLE Registry Study. J Rheumatol. 2020. 47. (1):p. 89-98. IF:4,666. (2).